Equine CCL11 induces eosinophil cytoskeletal reorganization and activation.

The research investigates the impact of a chemokine called equine CCL11 on the functioning of eosinophils (a type of white blood cell) in horses. The study reveals that equine CCL11 causes significant changes in eosinophils’ actin – a protein involved in cell movement – and their migration ability, suggesting that the chemokine could regulate the movement of these cells in horses.

Introduction and Method

• The study aims to understand the effects of a chemokine (a type of signaling protein), named equine CCL11, on the functioning of eosinophils, which are white blood cells involved in immune responses, in horses.
• The researchers used a purified recombinant version of equine CCL11 to simulate eosinophils sourced from healthy horses.
• The effect of the chemokine on the actin protein within these cells was assessed by measuring the polymerised form of actin using flow cytometry. This process was enabled by labeling the actin with a fluorescent material called phalloidin.
• The migration ability of eosinophils was gauged through a chemotaxis assay (a method to study cell movement) involving a 96-well plate and 8-microm pore membranes.
• A colorimetric assay (a method to measure chemical concentrations) for eosinophil peroxidase was used to analyze the adherence of these cells to serum-coated plastic.
• The production of superoxide, a type of molecule involved in immune responses, was also measured using a colorimetric assay.

Results and Conclusion

• The results revealed that equine CCL11 significantly and dependently influenced actin polymerisation and eosinophil migration.
• However, the stimulation with CCL11 did not have a significant effect on the cells’ adherence to serum-coated plastic or their production of superoxide.
• These findings led to the conclusion that equine CCL11 has a stimulating effect on the reorganisation of the cytoskeleton (the internal framework of cells) and the migration of equine eosinophils.
• Therefore, the researchers propose that equine CCL11 may play a role in controlling the movement and distribution of these white blood cells in horses.